Results 141 to 150 of about 8,196,711 (316)
Molecular Oncology, EarlyView.The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song +11 more
wiley +1 more source
A X-Band Integrated Passive Device Structure Based on TMV-Embedded FOWLP. [PDF]
Micromachines (Basel)Yang J, Xu L, Yin X, Yang K.
europepmc +1 more source
II.—Introduction to the general Structure of the Cumbrian Mountains; with a Description of the great Dislocations by which they have been separated from the neighbouring Carboniferous Chains. [PDF]
Adam C. Sedgwick
openalex +1 more source
FINE STRUCTURE OF CHROMOSOMES [PDF]
, 1956 Berwind P. Kaufmann, Deepesh N. De
openalex +1 more source
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
Lightweight dynamic model for fusion of three-dimensional surface-stratum underground structures. [PDF]
PLoS OneZhou C +5 more
europepmc +1 more source
On the Physical Structure of West Somerset and North Devon, and on the Palæontological Value of the Devonian Fossils [PDF]
R. Etheridge
openalex +1 more source
THE ROLE OF WATER IN THE STRUCTURE OF PERIPHERAL NERVE MYELIN [PDF]
, 1957 J.B. Finean
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source